Literature DB >> 14709612

Primary Ewing's sarcoma of the paranasal sinus with intracranial extension: imaging features.

M Harman1, F Kiroğlu, M Kösem, O Unal.   

Abstract

Extraskeletal Ewing's sarcoma is often described as a tumour involving the soft tissues of the lower extremities and the paravertebral region. Involvement of the paranasal sinus is a very rare entity. We present a case of primary Ewing's sarcoma of the paranasal sinus extending into the middle cranial fossa in a 40-year-old female. CT and MRI findings of this unusual case are discussed. To our knowledge, this case is the first to be reported with CT and MRI documentation.

Entities:  

Mesh:

Year:  2003        PMID: 14709612     DOI: 10.1259/dmfr/17098962

Source DB:  PubMed          Journal:  Dentomaxillofac Radiol        ISSN: 0250-832X            Impact factor:   2.419


  5 in total

1.  Efficacy of Proton Beam Therapy in the Treatment of Ewing's Sarcoma of the Paranasal Sinuses and Anterior Skull Base.

Authors:  Stacey Tutt Gray; Yen-Lin Chen; Derrick T Lin
Journal:  Skull Base       Date:  2009-11

2.  Ewing's family of tumors of the sinonasal tract and maxillary bone.

Authors:  Sara Hafezi; Raja R Seethala; Edward B Stelow; Stacey E Mills; Iona T Leong; Elaine MacDuff; Jennifer L Hunt; Bayardo Perez-Ordoñez; Ilan Weinreb
Journal:  Head Neck Pathol       Date:  2010-11-25

3.  Primary extraskeletal Ewing's sarcoma of the maxilla with intraorbital extension.

Authors:  Saurabh Varshney; S S Bist; Nitin Gupta; Rajat Bhatia
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2007-10-05

Review 4.  Multimodality Treatment in Ewing's Sarcoma Family Tumors of the Maxilla and Maxillary Sinus: Review of the Literature.

Authors:  David Thorn; Christoph Mamot; Fatime Krasniqi; Frank Metternich; Sven Prestin
Journal:  Sarcoma       Date:  2016-06-16

5.  Treatment, outcomes, and demographics in sinonasal sarcoma: a systematic review of the literature.

Authors:  Mitchell R Gore
Journal:  BMC Ear Nose Throat Disord       Date:  2018-03-21
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.